VYGR Voyager Therapeutics, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Voyager Therapeutics, Inc. (VYGR) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 9, 2026, a 10-Q quarterly report filed on November 10, 2025, an 8-K current report filed on April 21, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Voyager Therapeutics, Inc. (VYGR) (SEC CIK 1640266), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full-year 2025 earnings released March 9, 2026 via press release (Exhibit 99.1)
- • Full financial details in Exhibit 99.1 — primary source for revenue, cash position, and pipeline spending
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Voyager Therapeutics, Inc. (VYGR) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 21, 2026 | — | — | — |
8-K | Mar 9, 2026 | — | Analysis | — |
10-K | Mar 9, 2026 | Dec 31, 2025 | — | |
8-K | Feb 12, 2026 | — | — | |
8-K | Jan 8, 2026 | — | — | |
10-Q | Nov 10, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 6, 2025 | Jun 30, 2025 | — | |
10-Q | May 6, 2025 | Mar 31, 2025 | — | |
10-K | Mar 11, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 6, 2024 | Jun 30, 2024 | — | |
10-Q | May 13, 2024 | Mar 31, 2024 | — | |
10-K | Feb 28, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 6, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 3, 2023 | Jun 30, 2023 | — | |
10-Q | May 9, 2023 | Mar 31, 2023 | — | |
10-K | Mar 7, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 8, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 4, 2022 | Jun 30, 2022 | — | |
10-Q | May 4, 2022 | Mar 31, 2022 | — | |
10-K | Mar 8, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 2, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 9, 2021 | Jun 30, 2021 | — | |
10-Q | May 10, 2021 | Mar 31, 2021 | — | |
10-K | Feb 25, 2021 | Dec 31, 2020 | — |
Frequently Asked Questions
What are the latest VYGR SEC filings in 2026?
Voyager Therapeutics, Inc. (VYGR) has filed a 10-K annual report on March 9, 2026, a 10-Q quarterly report on November 10, 2025, an 8-K current report on April 21, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did VYGR file its most recent 10-K annual report?
Voyager Therapeutics, Inc. (VYGR) filed its most recent 10-K annual report on March 9, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view VYGR 10-Q quarterly reports?
Voyager Therapeutics, Inc. (VYGR)'s most recent 10-Q quarterly report was filed on November 10, 2025. SignalX displays every VYGR 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has VYGR filed recently?
Voyager Therapeutics, Inc. (VYGR)'s most recent 8-K was filed on April 21, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find VYGR insider trading activity (Form 4)?
SignalX aggregates every VYGR Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does VYGR file with the SEC?
Voyager Therapeutics, Inc. (VYGR) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new VYGR filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Voyager Therapeutics, Inc. (VYGR).
What is VYGR's SEC CIK number?
Voyager Therapeutics, Inc. (VYGR)'s SEC CIK (Central Index Key) number is 1640266. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1640266 to look up all VYGR filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find VYGR return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Voyager Therapeutics, Inc. (VYGR) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Voyager Therapeutics, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 46+ filings.